Insights

Innovative Product Development FocusStart is actively developing advanced inhaled medication management systems, indicating a strong emphasis on respiratory healthcare technology which presents opportunities to collaborate on new device solutions and integrations.

Market Recognition The company received the Best New Business 2014 Alley Award, reflecting industry acknowledgment and potential credibility for strategic partnerships and investor interest in expanding their innovative product portfolio.

Funding and Revenue Potential With revenue up to 1 million dollars and no disclosed funding, FocusStart may be open to additional financial partnerships, grants, or investment opportunities to accelerate product commercialization.

Strategic Location Advantage Located in Minneapolis with proximity to major medical clusters and healthcare providers, FocusStart offers a strategic entry point for sales efforts aimed at local hospitals, clinics, and respiratory treatment centers.

Growing Industry Focus Operating within the healthcare devices sector, particularly respiratory management, aligns FocusStart with increasing market trends driven by rising chronic respiratory diseases and personalized medicine, making them a promising partner for health tech collaborations.

FocusStart Tech Stack

FocusStart uses 8 technology products and services including RSS, Squarespace Commerce, Google Fonts API, and more. Explore FocusStart's tech stack below.

  • RSS
    Content Management System
  • Squarespace Commerce
    E-commerce
  • Google Fonts API
    Font Scripts
  • Stimulus
    Javascript Frameworks
  • Choices
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • HSTS
    Security
  • Adobe Fonts
    Web Fonts

FocusStart's Email Address Formats

FocusStart uses at least 1 format(s):
FocusStart Email FormatsExamplePercentage
Last@focusstart.comDoe@focusstart.com
50%
Last@focusstart.comDoe@focusstart.com
50%

Frequently Asked Questions

What is FocusStart's official website and social media links?

Minus sign iconPlus sign icon
FocusStart's official website is focusstart.com and has social profiles on LinkedIn.

What is FocusStart's SIC code NAICS code?

Minus sign iconPlus sign icon
FocusStart's SIC code is 3845 - Electromedical and Electrotherapeutic Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does FocusStart have currently?

Minus sign iconPlus sign icon
As of December 2025, FocusStart has approximately 2 employees across 1 continents, including North America. Key team members include Managing Member: J. R.: D. I.. Explore FocusStart's employee directory with LeadIQ.

What industry does FocusStart belong to?

Minus sign iconPlus sign icon
FocusStart operates in the Medical Equipment Manufacturing industry.

What technology does FocusStart use?

Minus sign iconPlus sign icon
FocusStart's tech stack includes RSSSquarespace CommerceGoogle Fonts APIStimulusChoicesModernizrHSTSAdobe Fonts.

What is FocusStart's email format?

Minus sign iconPlus sign icon
FocusStart's email format typically follows the pattern of Last@focusstart.com. Find more FocusStart email formats with LeadIQ.

When was FocusStart founded?

Minus sign iconPlus sign icon
FocusStart was founded in 2012.

FocusStart

Medical Equipment ManufacturingMinnesota, United States2-10 Employees

FocusStart is a medical device company located in the Twin Cities of Minneapolis and Saint Paul. Developing devices from concept to commercialization.

Section iconCompany Overview

SIC Code
3845 - Electromedical and Electrotherapeutic Apparatus
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • $1M

    FocusStart's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    FocusStart's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.